Breaking News Instant updates and real-time market news.

ALXN

Alexion

$105.87

6.645 (6.70%)

13:37
10/23/19
10/23
13:37
10/23/19
13:37

Alexion execution 'remains undervalued,' says William Blair

William Blair analyst Raju Prasad says Alexion Pharmaceuticals' execution "remains undervalued" following the company's Q3 results. The company continues to diversify its pipeline through expansion into new indications and business development deals, resulting in 22 development programs across 11 assets, Prasad tells investors in a research note. He believes Alexion has the potential to address over 15 different indications spanning ultra rare and rare diseases and addressing sizable patient populations. With 10 potential launches by 2023, the next two years are expected to be "catalyst-rich," contends Prasad, who keeps an Outperform rating on Alexion shares.

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

ALXN Alexion
$105.87

6.645 (6.70%)

10/16/19
PIPR
10/16/19
NO CHANGE
Target $180
PIPR
Overweight
Piper likes Alexion acquisition of Achillion, remains buyer of shares
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Alexion Pharmaceuticals (ALXN) with a $180 price target after this morning's announced acquisition of Achillion Pharmaceuticals (ACHN). The deal brings in danicopan, an oral Factor D inhibitor, as combination therapy with Soliris for the treatment of paroxysmal nocturnal hemoglobinuria and monotherapy for C3 glomerulopathy, and ACH-5228, a second generation oral Factor D inhibitor, expected to enter the clinic early next year, Raymond tells investors in a research note. The analyst likes the deal. Achillion has already shown proof of concept in PNH and strategically the company adds to the diversification of Alexion's pipeline, says Raymond. The analyst remains a buyer of Alexion shares.
10/17/19
BOFA
10/17/19
INITIATION
Target $130
BOFA
Buy
Alexion reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham reinstated coverage of Alexion Pharmaceuticals with a Buy rating and $130 price target. "Noise" around complement competition has overshadowed Alexion's "strong" fundamentals, driven by its Soliris/Ultomiris franchise, Meacham tells investors in a research note. The analyst likes the stock's risk/reward profile given the company's "differentiated" growth and "discounted" valuation.
10/18/19
LEER
10/18/19
DOWNGRADE
Target $6.3
LEER
Market Perform
Achillion acquisition by Alexion 'makes logical sense,' says SVB Leerink
SVB Leerink analyst Joseph Schwartz downgraded Achillion (ACHN) to Market Perform from Outperform with a price target of $6.30, up from $5. In a research note to investors, Schwartz says he thinks Alexion's (ALXN) proposed acquisition of Achillion makes logical sense as it brings highly complementary assets that can deliver a broader market opportunity together at a time "when the complement space could get more competitive." The analyst thinks the deal will close without any competing bids.
10/23/19
PIPR
10/23/19
NO CHANGE
PIPR
Piper a buyer of Alexion after 'another quarter of flawless execution'
Piper Jaffray analyst Christopher Raymond said he remains a buyer of shares of Alexion following what he describes as "yet another beat/raise quarter with near flawless execution both commercially and developmentally." Despite similar results in the past several quarters, the stock "has languished," which Raymond attributes to what he views as overblown concerns regarding the tail trajectory for the company's C5 inhibitor franchise. However, Raymond contends that Ultomiris conversion is "well ahead of schedule," which the company is coupling "with an almost breathtaking pace of BD-driven pipeline diversification." He maintains an Overweight rating and $180 price target on Alexion shares.

TODAY'S FREE FLY STORIES

NEWR

New Relic

$65.17

0.62 (0.96%)

, W

Wayfair

$82.03

-1.685 (-2.01%)

13:46
11/14/19
11/14
13:46
11/14/19
13:46
Hot Stocks
Tiger Global adds New Relic, Wayfair and Beyond Meat during Q3 »

Chase Coleman's…

NEWR

New Relic

$65.17

0.62 (0.96%)

W

Wayfair

$82.03

-1.685 (-2.01%)

PLAN

Anaplan

$47.82

-1.28 (-2.61%)

WORK

Slack Technologies

$21.21

-0.09 (-0.42%)

BYND

Beyond Meat

$80.80

1.82 (2.30%)

PVTL

Pivotal Software

$15.00

-0.01 (-0.07%)

LK

Luckin Coffee

$21.54

0.105 (0.49%)

BABA

Alibaba

$181.75

-0.73 (-0.40%)

FB

Facebook

$192.10

-1.1 (-0.57%)

CVNA

Carvana

$77.87

2.79 (3.72%)

RUN

Sunrun

$14.35

0.575 (4.17%)

RNG

RingCentral

$167.60

0.09 (0.05%)

FCAU

Fiat Chrysler

$16.00

0.1 (0.63%)

SVMK

SurveyMonkey

$16.69

0.29 (1.77%)

SPOT

Spotify

$148.49

1.72 (1.17%)

STNE

StoneCo

$36.40

0.43 (1.20%)

RDFN

Redfin

$20.42

0.36 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 04

    Dec

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 19

    Dec

  • 13

    Nov

LIQT

LiqTech

$4.71

-2.4 (-33.76%)

13:44
11/14/19
11/14
13:44
11/14/19
13:44
Recommendations
LiqTech analyst commentary  »

LiqTech post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WB

Weibo

$44.06

-8.75 (-16.57%)

13:35
11/14/19
11/14
13:35
11/14/19
13:35
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DF

Dean Foods

$0.00

(0.00%)

13:32
11/14/19
11/14
13:32
11/14/19
13:32
Hot Stocks
Dean Foods receives court approval of 'first day' motions to support operations »

Dean Foods announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$196.01

9.01 (4.82%)

13:28
11/14/19
11/14
13:28
11/14/19
13:28
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

13:28
11/14/19
11/14
13:28
11/14/19
13:28
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

WDC

Western Digital

$50.31

-0.75 (-1.47%)

13:25
11/14/19
11/14
13:25
11/14/19
13:25
Options
Western Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

13:23
11/14/19
11/14
13:23
11/14/19
13:23
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

GOOG

Alphabet

$1,309.36

11.75 (0.91%)

, GOOGL

Alphabet Class A

$1,308.00

12 (0.93%)

13:20
11/14/19
11/14
13:20
11/14/19
13:20
Hot Stocks
Google to no longer include contextual content categories in ad bid requests »

Alphabet's Google…

GOOG

Alphabet

$1,309.36

11.75 (0.91%)

GOOGL

Alphabet Class A

$1,308.00

12 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/14/19
11/14
13:17
11/14/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/14/19
11/14
13:16
11/14/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
11/14/19
11/14
13:15
11/14/19
13:15
General news
NY Fed's Williams repeated the new mantra that the economy and policy are "in a good place," »

NY Fed's Williams…

RBBN

Ribbon Communications

$3.05

-1 (-24.69%)

13:13
11/14/19
11/14
13:13
11/14/19
13:13
Downgrade
Ribbon Communications rating change  »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$33.13

-0.23 (-0.69%)

, WVE

Wave Life Sciences

$27.77

-0.2 (-0.72%)

13:09
11/14/19
11/14
13:09
11/14/19
13:09
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JD

JD.com

$33.13

-0.23 (-0.69%)

WVE

Wave Life Sciences

$27.77

-0.2 (-0.72%)

RYTM

Rhythm Pharmaceuticals

$21.49

0.35 (1.66%)

JCP

J.C. Penney

$1.09

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 09

    Dec

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

, AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

13:09
11/14/19
11/14
13:09
11/14/19
13:09
Earnings
Notable companies reporting after market close »

Notable companies…

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

WPM

Wheaton Precious Metals

$26.64

0.05 (0.19%)

DLB

Dolby

$65.71

0.01 (0.02%)

HP

Helmerich & Payne

$39.57

0.31 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 06

    Jan

13:05
11/14/19
11/14
13:05
11/14/19
13:05
General news
Fed dove Bullard said policy is "considerably" more accommodative »

Fed dove Bullard said…

MDU

MDU Resources

$29.13

0.02 (0.07%)

13:02
11/14/19
11/14
13:02
11/14/19
13:02
Hot Stocks
MDU Resources increases quarterly dividend »

The MDU Resources Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$22.52

0.92 (4.26%)

13:01
11/14/19
11/14
13:01
11/14/19
13:01
Recommendations
ShotSpotter analyst commentary  »

ShotSpotter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$208.11

-0.44 (-0.21%)

, AMZN

Amazon.com

$1,754.91

1.07 (0.06%)

13:00
11/14/19
11/14
13:00
11/14/19
13:00
On The Fly
Fly Intel: What to watch in Nvidia earnings report »

Nvidia (NVDA) is…

NVDA

Nvidia

$208.11

-0.44 (-0.21%)

AMZN

Amazon.com

$1,754.91

1.07 (0.06%)

INTC

Intel

$57.97

0.05 (0.09%)

VMW

VMware

$165.99

0.25 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 09

    Dec

  • 09

    Dec

  • 06

    Jan

  • 23

    Jan

BABA

Alibaba

$182.49

0.01 (0.01%)

13:00
11/14/19
11/14
13:00
11/14/19
13:00
Options
$5.5M buy in Alibaba calls possibly closes »

$5.5M buy in Alibaba…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMZN

Amazon.com

$1,754.00

0.16 (0.01%)

, GOOG

Alphabet

$1,306.86

9.25 (0.71%)

12:55
11/14/19
11/14
12:55
11/14/19
12:55
Conference/Events
House Committee on Small Business to hold a hearing »

The Committee holds a…

AMZN

Amazon.com

$1,754.00

0.16 (0.01%)

GOOG

Alphabet

$1,306.86

9.25 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

TSLA

Tesla

$351.71

5.71 (1.65%)

12:49
11/14/19
11/14
12:49
11/14/19
12:49
Periodicals
Tesla's Model 3 and Model S regain Consumer Reports recommendation »

Two of Tesla's three…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIM

Alimera Sciences

$0.28

0.0355 (14.75%)

12:46
11/14/19
11/14
12:46
11/14/19
12:46
Hot Stocks
Alimera says stock to begin trading on post-reverse split basis on Nov. 15 »

Alimera Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FGEN

FibroGen

$34.67

0.09 (0.26%)

12:45
11/14/19
11/14
12:45
11/14/19
12:45
Options
FibroGen call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLDQ

Sears

$0.00

(0.00%)

, SHLD

Sears

$0.00

(0.00%)

12:44
11/14/19
11/14
12:44
11/14/19
12:44
Periodicals
Sears laying off hundreds of corporate employees, Business Insider reports »

Sears is laying off…

SHLDQ

Sears

$0.00

(0.00%)

SHLD

Sears

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.